Multiple Sclerosis. Biology 12 Nervous System Project

Similar documents
MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease

DOWNLOAD OR READ : MULTIPLE SCLEROSIS THE HISTORY OF A DISEASE PDF EBOOK EPUB MOBI

What is Multiple Sclerosis? Gener al information

Multiple Sclerosis , The Patient Education Institute, Inc. nr Last reviewed: 04/17/2017 1

Multiple Sclerosis. Brain Spinal Cord. Peripheral Nerves

Get on with life, we ll see you. in 6 months. Living your life your way with MS

MULTIPLE SCLEROSIS INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

Multiple Sclerosis Diagnosis And Therapy

Multiple Sclerosis. What is multiple sclerosis? What is the cause? What are the symptoms?

Frequently Asked Questions For persons with multiple sclerosis

Progress in MS: Current and Emerging Therapies. Presented by: Dr. Kathryn Giles, MD MSc FRCPC Cambridge, Ontario, Canada

Relapses Matter A GUIDE TO REPORTING MULTIPLE SCLEROSIS SYMPTOMS

The Complete Guide To Multiple Sclerosis Symptoms: How To Manage Multiple Sclerosis, MS Pain And Control MS Disease Naturally By Benjamin Weber

Investor Update. Downloads. Services PDF. Basel, 17 July 2017

TECFIDERA (dimethyl fumarate) oral capsule

DOWNLOAD OR READ : MULTIPLE SCLEROSIS PDF EBOOK EPUB MOBI

PROGRESSIVE MULTIPLE SCLEROSIS

DOWNLOAD OR READ : MULTIPLE SCLEROSIS HOW I WON THE BATTLE PDF EBOOK EPUB MOBI

MULTIPLE SCLEROSIS PROFILE

Multiple Sclerosis. By: Selena Fucci April 22, 2016

AUBMC Multiple Sclerosis Center

Media Release. Basel, 10 November 2017

GILENYA (fingolimod) oral capsule

Roche s OCREVUS (ocrelizumab) approved in Switzerland for primary progressive and relapsing forms of multiple sclerosis

Advances in Progressive MS Research. Nicholas LaRocca, PhD

GILENYA (fingolimod) oral capsule

MS Ireland s Opinion On The Introduction of Sativex

About MS. An Overview of Multiple Sclerosis (MS), Including Symptoms, Treatments, and Research

Choices. Types of MS. Read me

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 4: Myelin diseases of the CNS

BASI PILATES IMPACT OF PILATES EXERCISE IN MULTIPLE SCLEROSIS

Multiple Sclerosis. What types of MS are there? 4 There are 4 types of MS.

The Nervous System. We have covered many different body systems which automatically control and regulate our bodies.

Treatment Expectations and Priorities of People with MS

Positive Phase III results for Roche s investigational medicine OCREVUS (ocrelizumab) published in New England Journal of Medicine

AUBAGIO (teriflunomide) oral tablet

neurological rehabilitation multiple sclerosis

Concerns for Special Patient

Biologics and Beyond: Treatment of Multiple Sclerosis. Rita Jebrin, PharmD, BCPS

Le Hua, MD. Disclosures Teaching and Speaking: Teva Neurosciences, Genzyme, Novartis Advisory Board: Genzyme, EMD Serono

While MS sometimes causes severe disability, it is only rarely fatal and most people with MS have a normal life expectancy.

MULTIPLE SCLEROSIS - REVIEW AND UPDATE

Innovation immunomodulatory treatment case study of men diagnosed with relapsing-remitting multiple sclerosis (MS)

Prof. Dimitrios Karussis Director of the Hadassah Center for MS

387

Understanding your Tecfidera. treatment. Information for patients who have been prescribed treatment with Tecfidera.

Chapter 7. The Nervous System

Kaspar Rufibach Methods, Collaboration, and Outreach Group (MCO) Department of Biostatistics, Roche Basel

A very simplified introduction to neuromuscular illnesses (NMIs) with a particular focus on the muscular dystrophies.

Plan to Stay in Shape Today IMMUNE SYSTEM 3 DISEASES CROHN S DISEASE RHEUMATOID ARTHRITIS MULTIPLE SCLEROSIS

Chronic Inflammatory Demyelinating Polyneuropathy (C.I.D.P.)

Thinking and Memory in MS

Novel therapeutic modality of Apitherapy for controlling of Multiple Sclerosis

Chandler, Chris, Daniel, & Jordon

SUBHAN ALLAH US/CANADIAN PHARMACY EXAMS EDNAN UNDERSTANDING MULTIPLE SCLEROSIS (MS) COPY RIGHT PROTECTED Page 1

Effects of Temperature on Neuromuscular Function. Jon Marsden School of Health Professions University of Plymouth

Endpoints in a treatment trial in NMO: Clinician s view. Anu Jacob Consultant Neurologist The Walton Centre, Liverpool,UK

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

35-2 The Nervous System Slide 1 of 38

A Case Study: Multiple Sclerosis. Kayla Jensen February 2013

Do you or did you have any family members who have been diagnosed with MS? Yes No I Don t Know. Yes identical Yes not identical No

MS Learn Online. and. Holly: this time. for others. >>Kate

Neurons Chapter 7 2/19/2016. Learning Objectives. Cells of the Nervous System. Cells of the Nervous System. Cells of the Nervous System

Certificate of Merit in Disorders of the Body Lesson 2: Epilepsy, Diabetes and Multiple Sclerosis

Multiple Sclerosis and Neuroinflammation: Considering Gender differences to design therapeutic agents HALINA OFFNER

Neurons, Synapses, and Signaling

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

News Release. March 29, 2019

Media Release. Basel 12 January 2018

PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M / F Year Month Day

Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score

Central nervous system

Multiple Sclerosis Research Program

Annex IV Scientific conclusions

COPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED

MS Research Australia MS Community Consultation on Priorities for MS Research EXECUTIVE SUMMARY

Social relationships, knowledge and adjustment to multiple sclerosis

Epidemiology, Diagnosis, Natural History & Clinical Course

Rapid Recovery Hyperbarics 9439 Archibald Ave. Suite 104 Rancho Cucamonga CA,

Mitzi Joi Williams, MD Neurologist MS Center of Atlanta Atlanta, GA

Depression management: Emotional Disorders in Multiple Sclerosis

DOWNLOAD OR READ : NERVOUS AND MENTAL DISEASE MONOGRAPH SERIES NO 4 SELECTED PAPERS ON HYSTERIA AND OTHER PSYCHONEUROSES PDF EBOOK EPUB MOBI

Nervous System. Lesson 11

Mediators of Employment Status and Depression in Multiple Sclerosis

Teacher Key. Big Idea Different types of neurons compose the nervous tissue that forms the communication system within the body.

-The process by which organisms maintain, control, and coordinate their internal environment with a constantly changing external environment

ND Lesson 2.5 Jigsaw Case Study #1

HIGH LEVEL - Science

Glutamate. By: Sascha Ridgewell, Hannah Straughan, Hunter Scripture, Caitlyn Wibbels, & Angelina Sutton

Efficacy of interferon beta-1b as a first-line treatment in patients with Radiologically Isolated Syndrome

Chapter Six Review Sections 1 and 2

Disease of Myelin. Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019

AMPYRA (dalfampridine) extended release oral tablet Dalfampridine ER oral tablet

The Impact of Multiple Sclerosis in the. James Bowen, MD Multiple Sclerosis Center

Dr. Terry Wahls Interview pitch. Bio

DISORDERS OF THE NERVOUS SYSTEM

LESSON 2.5 WORKBOOK. What if there are problems conducting action potentials?

Medication Policy Manual. Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013

Hot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018

Neurons, Synapses, and Signaling

Transcription:

Multiple Sclerosis Biology 12 Nervous System Project

Overview Multiple Sclerosis (MS) is a progressive and unpredictable disorder that affects the central nervous system. Figure 1: The central nervous system is comprised of the brain and spinal cord.

What is a relapse? An attack, worsening or flare up of the disease. Worsening of symptoms. Medical providers call an attack a relapse if: Old symptoms become worse or new symptoms appear. Symptoms least at lease 24 hours. Occurs at least 30 days after last relapse. There is no other explanation for symptoms (ie. Flu)

4 Types of MS Type Relapsing-Remitting MS (RRMS) Secondary-Progressive MS (SPMS) Primary-Progressive MS (PPMS) Progressive-Relapsing MS (PRMS) Characteristics This is the most common form of multiple sclerosis. About 85% of people with MS are initially diagnosed with RRMS. People with RRMS have temporary periods called relapses, flare-ups or exacerbations, when new symptoms appear. In SPMS, symptoms worsen more steadily over time, with or without the occurrence of relapses and remissions. Most people who are diagnosed with RRMS will transition to SPMS at some point. This type of MS is not very common, occurring in about 10% of people with MS. PPMS is characterized by slowly worsening symptoms from the beginning, with no relapses or remissions A rare form of MS (5%), PRMS is characterized by a steadily worsening disease state from the beginning, with acute relapses but no remissions, with or without recovery. Table 1: Types of MS.

Image 2: Relapses and progression of symptoms dictate classification of the type of MS.

Cause The cause of MS is not know, despite extensive research. It is likely that MS is an auto-immune disease. A healthy immune system defends the body against disease. Autoimmune diseases cause the immune system to mistake healthy cells for intruders, and therefore, attack them.

Cause: Contributing Factors Lifestyle, environmental, genetic and biological factors could all contribute to a person s susceptibility to the disease.

It is not thought that genetic mutations cause MS. Instead, the perfectly healthy genes could have very subtle variations that do not fit together properly. The immune system, the brain and the spinal cord would be most impacted. MS is known to occur more frequently in areas that are farther from the equator. This could be explained by the growing evidence that suggests that vitamin D plays an important role. People who live near the equator are exposed to greater amounts of sunlight, allowing them to naturally produce more vitamin D, which is important for immune system function. Another theory is that a common virus could act as a stimulus by entering the brain and influencing the immune system.

Structures of Nervous System that MS Disrupts/Destroys MS a result of damage to the myelin. Myelin is the sheath that covers (usually) the axon in a neuron. Myelin insulates and protects the axon and helps speed nerve transmission. Myelin is present in both the central nervous system and peripheral nervous system. Central nervous system and peripheral nervous system myelin is different chemically, but serves the same function. However, only the central nervous system is affected by MS. When the myelin is damaged, the messages from the brain to other bits of the body are affected. It is believed that the immune system attacks the myelin.

Image 3: Healthy nerve cell vs. nerve cell damaged by MS

Symptoms There is great variety and inconsistency in symptoms. There is no typical case. Symptoms can include: Balance/Dizziness Bladder or bowel dysfunction. Cognitive Impairment Depression Fatigue Gait (difficulty in walking) Optic neuritis (Inflammation of the optic nerve) Paroxysmal Symptoms (cluster of symptoms if they occur over several days, it could be a MS relapse.) Sensory Impairment, Numbness / Tingling Sexual Dysfunction Spasticity Tremor Uhthoff's Phenomena (Heat Intolerance) Weakness

Image 4: MS often causes numbness, which usually originates in the limbs.

Treatment There is no cure for MS, but there are a variety of treatments.

Treatment name Disease-modifying therapies (DMTs) Relapse management therapies Symptom management therapies Alterative medicine Rehabilitation and Physical Therapy Method Medication that works on relapses and progression. Steroid medications. If used over the long term there are severe side effects. Work to reduce inflammation in specific areas of central nervous system, and therefore, reduce the severity of relapses. Help ease symptoms, rather than alter disease itself Includes acupuncture, naturopathy, homeopathy and others. Aims to improve and strengthen physical function. Table 2: Treatments for MS.

Image 5: Physical therapy. Image 6: Acupuncture, an alternative therapy.

Number of People Affected It is estimated that more than 2.3 million people are affected by MS worldwide. (National MS Society) Because diagnosis is difficult and symptoms vary, it is difficult to know an exact number.

Mortality Rate There is difficulty in collecting data relating to death due to MS because of data collected in different places, at different time. Therefore, data varies. MS reduces life expectancy in patients compared to the general population by 7-14 years, according to a 2013 study. MS is the main cause of death in 50% of patients, according to the same study. In people affected by MS, the suicide rate is significantly higher than the general population.

Image 7: Mortality Rates for MS.

Further Enquiries Learning about the impact on the neurons was very interesting! It was challenging to come to clear conclusions since so little is know about the causes. The exciting aspect of learning about MS is that there is so much ongoing research and areas for further enquiry. In the future, I would like to learn more about how environmental and genetic factors can influence susceptibility to the disease.

Bibliography MS International Federation. (n.d.). Retrieved November 30, 2015, from http://www.msif.org Multiple Sclerosis FAQs. (n.d.). Retrieved November 30, 2015, from http://www.nationalmssociety.org/what-is-ms/ms-faq-s#question-what-arethe-typical-symptoms-of-ms Multiple Sclerosis Society of Canada. (n.d.). Retrieved November 30, 2015, from https://beta.mssociety.ca Multiple sclerosis. (2015, October 1). Retrieved November 30, 2015, from http://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/home/ovc- 20131882 Myelin. (n.d.). Retrieved November 30, 2015, from http://www.nationalmssociety.org/what-is-ms/definition-of-ms/myelin Scalfari, A., Knappertz, V., Cutter, G., Goodin, D. S., Ashton, R., & Ebers, G. C. (2013). Mortality in patients with multiple sclerosis. Neurology, 81(2), 184 192. http://doi.org/10.1212/wnl.0b013e31829a3388